Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
CHEMOPHARMALABORATORIES
LIMITED
Registered Office: 5-Kumud Apartment Co. Op. HSG. Sac. Ltd., Karnik Road, Chikan Ghar, Kalyan, Dist. Thane - 421301
. CorporateOffice: - Empire House, 3'dPloor, 214, Dr. D. N. Road, Port, Mumbai - 400 001
No.: AAACC2056K
Email ID:chemopharmalab@gmail.com
To,
Bombay Stock Exchange Ltd.
Department
of Corporate Services
25th Floor, P.J.Towers, Dalal Street,
Mumbai-400 001
Script ID
2017
506365
Subject
Dear Sirs,
1.
Regulation 33
.'
2.
Outcome
Thanking You.
Yours Faithfully,
FOR CHEMO PHARMA LABORATORIES LIMITED
"
,.
ASHOK SOMANI
DIRECTOR
(DIN NO. - 03063364)
Held on 23/01/2017
CHEMO
PHARMA
lABORATORIES
liMITED
REGISTERED
OFFICE: 5-KUMUD
APARTMENT
ROAD,CHIKAN
GHAR,
421301
FOR THE QUARTER AND NINE MONTHS ENDED ON 31ST DECEMBER, 2016
(Rs. in Thousand)
STANDLONE
Quarter
Sr.
No.
Particulars
Income
Crom Operations
(a) Net Sales/ Income from Operations
(b) Other Operating Income
Total Income Crom operations
Expenses
(a) Cost of materials
(b) Purchases
(net)
Unaudited
Unaudited
Audited
552
1,490
326
2,967
2,374
4,919
552
1,490
326
2,967
2,374
4,919
191
-
191
-
152
-
571
-
392
-
542
-
207
156
18
401
178
354
191
79
36
290
136
476
35
18
66
256
1,584
72
235
1,013
116
245
443
35
10
251
1,733
1,047
75
1,382
1,361
3,186
and amortisation
expense
624
(72)
items (5+6)
Unaudited
13
14
15
16
Unaudited
Year Ended
31st March,
2016
Unaudited
31st Dec.,
2015
consumed
(e) Depreciation
30th Sept.,
2016
Ended
31st Dec.,
2016
of Stock-in-trade
31st Dec.,
2016
31st Dec.,
2015
(Net of excise
Nine Months
Ended
'*
(72)
1,047
75
(721
1,382
(72)
1,047
1,361
3,186
1,382
1,361
3,186
1,361
3,186
75
1,047
75
1,382
(72)
1,047
75
1,382
1,361
(72)
-
1,047
-
75
-
1,382
-
1,361
-
2,168
(72)
1,047
75
1,382
1,361
2,168
1,018
2,168
15,000
15,000
15,000
15,000
15,000
15,000
38,385
38,385
37,503
38,385
37,503
38,385
(0.05)
0.70
0.05
0.92
0.91
1.45
(0.05)
0.70
0.05
0.92
0.91
1.45
items)
(b) IDiluted
,:~~
,. "."'"
'-.
80
f!0
II~""'-
~
.
~\
~-\.
AVO\
\i~
~ !
\" '"
;;; i
.-S-':--"
.v
-, .;""..." ,
'.~-!
~ .
.
.
CHEMOPHARMALABORATORIES
LIMITED
f'
REGISTERED OFFICE: 5-KUMUD APARTMENT CO. OP. HSG. SOc. LTD., KARNIK ROAD,CHIKAN GHAR, KALYAN, DIST. THANE- 421301
..
001
PARTICULARS OF SHAREHOLDING
Public Shareholding
- Number of shares
- Percentage
19 Promoters
10,81,719
'/2.12
of shareholding
1\),81,719
72.12
10,81,719
72.12
10,81,719
72.12
10,81,719
72.12
a) Pledged/Encumbered
- Number of shares
- Percentage
- Percentage
,
10,81,719
72.12
of
NIL
NIL
NIL
NIL,
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
4,18,281
100
4,18,281
100
27.88
27.88
4,18,281
100
27.88
4,18,281
100
4,18,281
100
4,18,281
100
27.88
27.88
27.88
Note:
The above Un-Audited Financial Results for the quarter and nine months ended 31.12.2016 have been reviewed by the Audit
Committee in their Meeting held on 23.01.2017 and approved by the Board of Directors ofits Meeting held on 23.01.2017. The
Limited Review Report of Auditors Mis VMD & Co. was also taken on record by the Board in its Meeting.
2
For Chemo
Place:
Date:
Mumbai
23rd January,
2017
,.
- Pharma
~'Director
VMD &
co.
AVMS PREMISES,
4THFLOOR,
SHREENIWAS HOUSE,
27, H.S. MARG, FORT,
MUMBAI- 400 001
Telefax: +91 22 2207 7707
Email: info@vmd.co.in
www.vmd.co.in
CHARTERED ACCOUNTANTS
~
We have reviewed the accompanying Statement of unaudited financial results of MIS CHEMOPHARMA
LABORATORIESLTD., Mumbai for the quarter ended 31st December; 2016.
responsibility of the Company's management and has been approved by the Board of Directors
committee of Board of Directors. Our responsibilityis to issue a report on these financialstatements based
on our review.
We conducted our review in accordance with the Standard on Review Engagement (SRE) 2400,
Engagement to Review Financial Statements issued by the Institute-of Chartered Accountants of India.
This stanpard requires that we plan and perform the review to obtain moderate assurance as to whether
the financial statements are free of material misstatement. A review is limited to inquiries of company
personnel and analytical procedures applied to financial data and thus provide less assurance than an
audit. We have not performed an audit and accordingly,we do not express an audit opinion.
Based on our review conducted as above, nothing has come to our notice that causes us to believe that
the accompanying Statement of unaudited financial results prepared in accordance with applicable
Accounting Standards and other recognized accounting practices and polices has not disclosed the
information required to be disclosed in terms of Clause 41 of the ListingAgreement includingthe manner
in which it is to be disclosed, or that it contains any material misstatement.
kVZG=E
NO: Cj04jOl17
Dated:'2.."!j01j2017
Place: MUMBAI
,.
PARTNER
MRN: 114222
"